Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to -$976000.0.

  • Xtant Medical Holdings' Non Operating Income rose 1763.71% to -$976000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.1 million, marking a year-over-year decrease of 4360.51%. This contributed to the annual value of -$4.2 million for FY2024, which is 14591.6% down from last year.
  • As of Q3 2025, Xtant Medical Holdings' Non Operating Income stood at -$976000.0, which was up 1763.71% from -$819000.0 recorded in Q2 2025.
  • Over the past 5 years, Xtant Medical Holdings' Non Operating Income peaked at $10.3 million during Q3 2023, and registered a low of -$1.3 million during Q4 2024.
  • For the 5-year period, Xtant Medical Holdings' Non Operating Income averaged around -$28789.5, with its median value being -$466000.0 (2021).
  • As far as peak fluctuations go, Xtant Medical Holdings' Non Operating Income plummeted by 3580000.0% in 2022, and later surged by 244454.55% in 2023.
  • Over the past 5 years, Xtant Medical Holdings' Non Operating Income (Quarter) stood at -$466000.0 in 2021, then rose by 0.43% to -$464000.0 in 2022, then surged by 117.24% to $80000.0 in 2023, then crashed by 1677.5% to -$1.3 million in 2024, then increased by 22.66% to -$976000.0 in 2025.
  • Its last three reported values are -$976000.0 in Q3 2025, -$819000.0 for Q2 2025, and -$1.0 million during Q1 2025.